Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Pipeline Watch: Phase III Readouts In Atopic Dermatitis, Ischemic Stroke

Mon, 02/03/2020 - 12:47am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies...

      Related Stories 

US Approval For Peanut Allergy Therapy Palforzia

Mon, 02/03/2020 - 12:47am

Aimmune has secured approval for the first ever peanut allergy treatment, but safety, cost and administration issues could limit the...

      Related Stories 

Import Tax Waivers As China Slowly Reopens Amid Virus Battle

Sun, 02/02/2020 - 8:17pm

Import taxes waived for diagnostic testing agents for new virus, as China pharma sector faces uncertainty over extended holiday and...

      Related Stories 

Gilead Joins Coronavirus Fray With Repurposed Antiviral

Sun, 02/02/2020 - 4:03pm

US antiviral specialist Gilead is working to provide its experimental drug remdesivir to treat the China coronavirus, while other potential...

      Related Stories 

Roche Partnering Casts Wide Net To Expand Company’s Neuroscience Pipeline

Fri, 01/31/2020 - 11:11am

Roche completed 80 significant deals in 2019, neuroscience partnering head Tom Zioncheck said, many of which helped the company build...

      Related Stories 

Asia Deal Watch: China’s BravoVax, US-based GeoVax Team Up On Coronavirus Vaccine

Fri, 01/31/2020 - 9:15am

Deal news from GeoVax/BravoVax, Onconova/HanX, Zydus Cadila/China Medical System Holdings, EyePoint/Ocumension, Ningbo NewBay Medical/Genentech, Otsuka/PhoreMost, Almirall/WuXi Biologics

      Related Stories 

Stunning Start For Vertex Cystic Fibrosis Triple Combo

Fri, 01/31/2020 - 5:33am

Only nine weeks after US approval, Trikafta, which in theory can treat 90% of all patients with cystic fibrosis, is...

      Related Stories 

Brexit Finally Here But Uncertainty Not Over For Biopharma

Fri, 01/31/2020 - 4:50am

A free trade deal needs to be negotiated in record time and UK life sciences must face up to diverging...

      Related Stories 

Strides' New CEO Reiterates Strategy, Thrust On Execution

Fri, 01/31/2020 - 1:18am

Newly-appointed CEO at Strides, R Ananthanarayanan, sees no reason to change course as current strategy continues yielding positive results. Company posts...

      Related Stories 

Epidemic Expert Kang On Tackling nCoV And Science As A Leveler

Thu, 01/30/2020 - 10:13pm

Gagandeep Kang of the Translational Health Science and Technology Institute and Coalition for Epidemic Preparedness Innovations talks to Scrip about...

      Related Stories 

Virus Stresses China As Emerging Initial Response Provokes Anger

Thu, 01/30/2020 - 5:39pm

China research paper suggesting early cover-up of newly identified coronavirus stirs controversy and anger as reported China cases approach 10,000...

      Related Stories 

Lilly Calls It Quits On Pegilodecakin As Loxo Team Reorganizes Cancer R&D

Thu, 01/30/2020 - 11:43am

Revealing that the pegylated IL-10 therapy acquired in the Armo buyout two years ago has failed a pair of Phase...

      Related Stories 

Atopic Dermatitis: Ruxolitinib And Baracitinib Spearheading New Therapies

Thu, 01/30/2020 - 7:03am

Top-line Phase III results from Incyte’s TruE-AD2 study of ruxolitinib cream and Eli Lilly’s BREEZE-AD4 and BREEZE-AD5 studies of oral...

      Related Stories 

US Biosimilars Take A Bite Out Of Roche's Herceptin, But Tecentriq Surges

Thu, 01/30/2020 - 12:36am

Roche's Q4 and full year results are slightly below expectations, but analysts still see it as one of sector's strong...

      Related Stories